Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
| Website: | www.bruker.com |
| Email: | investor.relations@bruker.com |
| Main Phone: | +1 978 663-3660 |
| Address: | 40 Manning Road |
| State: | MA |
| City / Town: | Billerica |
| Country: | US |
| Postal Code: | 01821 |
| Exchange: | NGS |
| CEO: | Frank H. Laukien |
| Employees: | 7230 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
This will be a great year for life sciences tools and diagnostics companies, says Bryan Brokmeier of Maxim Group. And no, growth won't be driven by irrational exuberance, the senior analyst
The Dow Jones Industrial Average traded up to 12,830.29 in morning trading then dipped to 12,611.79 into the final half hour of trading, below its 50-day simple moving average at 12,697. The
Construction Spending in March was weaker than expected with a rise of just 0.1%. The ISM manufacturing index was stronger than expected in April at 54.8. The Dow Jones Industrial Average traded
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
| Website: | www.bruker.com |
| Email: | investor.relations@bruker.com |
| Main Phone: | +1 978 663-3660 |
| Address: | 40 Manning Road |
| State: | MA |
| City / Town: | Billerica |
| Country: | US |
| Postal Code: | 01821 |
| Exchange: | NGS |
| CEO: | Frank H. Laukien |
| Employees: | 7230 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
This will be a great year for life sciences tools and diagnostics companies, says Bryan Brokmeier of Maxim Group. And no, growth won't be driven by irrational exuberance, the senior analyst
The Dow Jones Industrial Average traded up to 12,830.29 in morning trading then dipped to 12,611.79 into the final half hour of trading, below its 50-day simple moving average at 12,697. The
Construction Spending in March was weaker than expected with a rise of just 0.1%. The ISM manufacturing index was stronger than expected in April at 54.8. The Dow Jones Industrial Average traded
| Last Price 39.90 | Change $ 0.41 | Change % 1.04 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 39.56 | High 40.48 | Low 39.56 | Prev Close 39.49 |
| Last Trade | Volume 677,380 | 52 Wk Hi 54.50 | 52 Wk Low 30.79 |
| Market Cap 6.1 bi | Ex-Div Date | Div Rate 0.16 | Yield 0.4010 |
| Shares 153,085,243.00 | EPS (TTM) 1.06 | PE Ratio 37.30 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 1 | 25 |
| Number of Buys | 0 | 19 |
| Number of Sells | 1 | 6 |
| Net Activity | -1384 | 184342 |
| Last 10 Buys | Shares |
|---|---|
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Richard A. Packer | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Mark Munch | 1,000 |
| Chris van Ingen | 1,000 |
| Richard D. Kniss | 1,000 |
| Mark Munch | 1,000 |
| Chris van Ingen | 1,000 |
| Joerg C. Laukien | 1,000 |
| Wolf-Dieter Emmerich | 1,000 |
| Brenda J. Furlong | 1,000 |
| Mark Munch | 1,000 |
| Joerg C. Laukien | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 38 | 38 | 38 | 38 |
| Low Target Price Estimate | 31 | 31 | 31 | 31 |
| Mean Target Price Estimate | 34.3 | 34.3 | 34.3 | 34.3 |
| Standard Deviation | 2 | 2 | 2 | 2 |
| Date of Most Recent Estimate | 06/01/18 | 05/04/18 | 05/04/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-06 |
| SD | Specialized Disclosure Report | 15 | 2018-05-31 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-21 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 55 | 2018-05-10 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-03 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 67 | 2018-04-17 |
| 10-K | Annual report with a comprehensive overview of the company | 149 | 2018-03-16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 10 | 10 | 10 | 10 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 |
| Mean Rec. | 2.67 | 2.67 | 2.67 | 2.85 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait